Apyx Medical Corporation (APYX)
NASDAQ: APYX · Real-Time Price · USD
0.9061
-0.0364 (-3.86%)
Apr 23, 2025, 4:00 PM EDT - Market closed
Apyx Medical Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 31.74 | 43.65 | 10.19 | 30.87 | 41.92 | Upgrade
|
| Cash & Short-Term Investments | 31.74 | 43.65 | 10.19 | 30.87 | 41.92 | Upgrade
|
| Cash Growth | -27.29% | 328.30% | -66.98% | -26.35% | -28.73% | Upgrade
|
| Accounts Receivable | 15.58 | 14.12 | 10.7 | 13.14 | 8.4 | Upgrade
|
| Other Receivables | - | - | 7.64 | 8.13 | 8.93 | Upgrade
|
| Receivables | 15.58 | 14.12 | 18.35 | 21.26 | 17.33 | Upgrade
|
| Inventory | 7.56 | 9.92 | 11.8 | 6.78 | 4.05 | Upgrade
|
| Prepaid Expenses | 1.56 | 2.66 | 2.64 | 1.83 | 2.8 | Upgrade
|
| Total Current Assets | 56.44 | 70.36 | 42.97 | 60.74 | 66.09 | Upgrade
|
| Property, Plant & Equipment | 6.74 | 7.15 | 7.59 | 6.87 | 7.22 | Upgrade
|
| Other Long-Term Assets | 1.66 | 1.73 | 1.22 | 1.11 | 0.81 | Upgrade
|
| Total Assets | 64.84 | 79.24 | 51.78 | 68.72 | 74.11 | Upgrade
|
| Accounts Payable | 2.62 | 2.71 | 2.67 | 2.63 | 1.51 | Upgrade
|
| Accrued Expenses | 3.46 | 5.21 | 3.78 | 6.69 | 4.69 | Upgrade
|
| Current Portion of Leases | 0.36 | 0.37 | 0.25 | 0.29 | 0.36 | Upgrade
|
| Current Unearned Revenue | 0.69 | 0.49 | 0.85 | 0.53 | - | Upgrade
|
| Other Current Liabilities | 3.6 | 3.97 | 4.3 | 3.07 | 2.59 | Upgrade
|
| Total Current Liabilities | 10.72 | 12.74 | 11.85 | 13.21 | 9.15 | Upgrade
|
| Long-Term Debt | 33.89 | 33.19 | - | - | - | Upgrade
|
| Long-Term Leases | 4.52 | 4.95 | 0.54 | 0.02 | 0.31 | Upgrade
|
| Long-Term Unearned Revenue | 1.12 | 1.25 | 1.41 | 1.32 | 0.62 | Upgrade
|
| Other Long-Term Liabilities | 0.26 | 0.2 | 0.18 | 0.17 | 0.17 | Upgrade
|
| Total Liabilities | 50.51 | 52.32 | 13.98 | 14.71 | 10.25 | Upgrade
|
| Common Stock | 0.04 | 0.04 | 0.04 | 0.03 | 0.03 | Upgrade
|
| Additional Paid-In Capital | 92.08 | 81.11 | 73.28 | 66.22 | 61.07 | Upgrade
|
| Retained Earnings | -77.91 | -54.45 | -35.74 | -12.55 | 2.62 | Upgrade
|
| Total Common Equity | 14.21 | 26.7 | 37.58 | 53.7 | 63.72 | Upgrade
|
| Minority Interest | 0.13 | 0.22 | 0.21 | 0.31 | 0.14 | Upgrade
|
| Shareholders' Equity | 14.34 | 26.92 | 37.79 | 54.01 | 63.86 | Upgrade
|
| Total Liabilities & Equity | 64.84 | 79.24 | 51.78 | 68.72 | 74.11 | Upgrade
|
| Total Debt | 38.76 | 38.5 | 0.8 | 0.31 | 0.68 | Upgrade
|
| Net Cash (Debt) | -7.02 | 5.15 | 9.4 | 30.57 | 41.24 | Upgrade
|
| Net Cash Growth | - | -45.18% | -69.26% | -25.88% | -28.50% | Upgrade
|
| Net Cash Per Share | -0.20 | 0.15 | 0.27 | 0.89 | 1.21 | Upgrade
|
| Filing Date Shares Outstanding | 37.79 | 34.64 | 34.6 | 34.43 | 34.32 | Upgrade
|
| Total Common Shares Outstanding | 37.79 | 34.64 | 34.6 | 34.41 | 34.29 | Upgrade
|
| Working Capital | 45.72 | 57.62 | 31.12 | 47.53 | 56.94 | Upgrade
|
| Book Value Per Share | 0.38 | 0.77 | 1.09 | 1.56 | 1.86 | Upgrade
|
| Tangible Book Value | 14.21 | 26.7 | 37.58 | 53.7 | 63.72 | Upgrade
|
| Tangible Book Value Per Share | 0.38 | 0.77 | 1.09 | 1.56 | 1.86 | Upgrade
|
| Land | - | - | 1.6 | 1.6 | 1.6 | Upgrade
|
| Buildings | - | - | 4.43 | 4.43 | 4.45 | Upgrade
|
| Machinery | 5.06 | 4.83 | 5.09 | 5.04 | 4.72 | Upgrade
|
| Construction In Progress | 0.64 | 0.4 | 0.51 | 0.65 | 0.42 | Upgrade
|
| Leasehold Improvements | 0.28 | 0.21 | 0.18 | 0.17 | 0.16 | Upgrade
|
Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.